Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2006 1
2008 3
2009 2
2010 2
2011 1
2012 1
2013 1
2014 3
2015 6
2017 3
2018 5
2019 2
2020 5
2021 7
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: yanagawa h. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.
Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: yanagawa h. Clin Infect Dis. 2022 Oct 12;75(8):1416-1422. doi: 10.1093/cid/ciac128. Clin Infect Dis. 2022. PMID: 35262686 Free PMC article.
Research Ethics Consultation in Nursing Studies.
Kane C, Sakaguchi S, Chuma M, Yagi K, Takechi K, Aoe Y, Takagai T, Yanagawa H. Kane C, et al. Among authors: yanagawa h. J Empir Res Hum Res Ethics. 2022 Feb-Apr;17(1-2):63-69. doi: 10.1177/15562646211036577. Epub 2021 Aug 10. J Empir Res Hum Res Ethics. 2022. PMID: 34374568
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis.
Nishiuchi S, Yagi K, Saito H, Zamami Y, Niimura T, Miyata K, Sakamoto Y, Fukunaga K, Ishida S, Hamano H, Aizawa F, Goda M, Chuma M, Izawa-Ishizawa Y, Nawa H, Yanagawa H, Kanda Y, Ishizawa K. Nishiuchi S, et al. Among authors: yanagawa h. Eur J Pharmacol. 2022 Aug 5;928:175083. doi: 10.1016/j.ejphar.2022.175083. Epub 2022 May 31. Eur J Pharmacol. 2022. PMID: 35659512 Free article.
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.
Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: yanagawa h. Basic Clin Pharmacol Toxicol. 2022 Dec;131(6):525-535. doi: 10.1111/bcpt.13799. Epub 2022 Oct 7. Basic Clin Pharmacol Toxicol. 2022. PMID: 36169161 Free article.
Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
Niimura T, Zamami Y, Miyata K, Mikami T, Asada M, Fukushima K, Yoshino M, Mitsuboshi S, Okada N, Hamano H, Sakurada T, Matsuoka-Ando R, Aizawa F, Yagi K, Goda M, Chuma M, Koyama T, Izawa-Ishizawa Y, Yanagawa H, Fujino H, Yamanishi Y, Ishizawa K. Niimura T, et al. Among authors: yanagawa h. J Clin Pharmacol. 2023 Apr;63(4):473-479. doi: 10.1002/jcph.2187. Epub 2022 Dec 21. J Clin Pharmacol. 2023. PMID: 36453166
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.
Haji S, Fujita K, Oki R, Osaki Y, Miyamoto R, Morino H, Nagano S, Atsuta N, Kanazawa Y, Matsumoto Y, Arisawa A, Kawai H, Sato Y, Sakaguchi S, Yagi K, Hamatani T, Kagimura T, Yanagawa H, Mochizuki H, Doyu M, Sobue G, Harada M, Izumi Y. Haji S, et al. Among authors: yanagawa h. JMIR Res Protoc. 2023 Jan 30;12:e42032. doi: 10.2196/42032. JMIR Res Protoc. 2023. PMID: 36716091 Free PMC article.
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis.
Kanda M, Goda M, Maegawa A, Yoshioka T, Yoshida A, Miyata K, Aizawa F, Niimura T, Hamano H, Okada N, Sakurada T, Chuma M, Yagi K, Izawa-Ishizawa Y, Yanagawa H, Zamami Y, Ishizawa K. Kanda M, et al. Among authors: yanagawa h. Clin Transl Sci. 2022 Jul;15(7):1664-1675. doi: 10.1111/cts.13282. Epub 2022 Apr 30. Clin Transl Sci. 2022. PMID: 35445533 Free PMC article.
55 results